Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30 ...
Discover Danaher's strong Q3 results, strategic reinvestments, and biotech growth. See why DHR is poised for future earnings ...
Baron Health Care Fund gained for the quarter and outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...
Patients gain hope through regenerative medicine doctors earn empowerment and recognition and India gains economic momentum through reduced chronic burden and enhanced GDP growth.Dr. Polisetty ...
In this article, we explore how AI, robotics and advanced software are transforming biopharma labs, the challenges of adopting these technologies and the vision for the “Lab of the Future.” ...
As the world looks toward the next decade, China's 15th Five-Year Plan signals confidence, continuity, and commitment — ...
Since interagency cooperation isn’t succeeding organically, it’s time for top-down initiatives led by a Health and Human ...
Forget the fancy Ferraris and precious Picassos. Instead, new Forbes 400 member David D. Halbert chose the ultimate flex: convincing Tom Fazio to build him a “no-budget” 18-hole golf course in Texas.
Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Good day, and welcome to the Alexandria Real Estate Equities’ ...
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...
With the new platform, researchers can speed up scientific discovery by using advanced AI and high-performance computing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results